Innovation and imitation,opportunity and challenge
Asia-Pacific Pharma IP Leader summit2019---14th-15th NOV, Beijing CHINAOn March 19, 2019, the World Intellectual Property Organization (WIPO) published its global intellectual property report 2018.Asian innovators filed more than half of their international patent applications through WIPO for the first time in 2018, with significant growth in China, India and South Korea, the report noted. As a technology-intensive industry, pharmaceutical industry attaches great importance to patent application and intellectual property protection.In recent years, the size of the global pharmaceutical market has maintained a steady growth, with China, South Korea, India and other emerging markets presenting a rapid growth momentum. Due to the different intellectual property policies of different countries, the strategic layout of global intellectual property, the differences of pharmaceutical intellectual property policies of Asia-pacific countries, the patent review process, litigation procedures and Generic drug patent strategy have gradually become the hot spots of the pharmaceutical intellectual property industry.In this context, the 2019 Asia-pacific Pharmaceutical IP Leader Summit will be held in Beijing on November 14-15, and will attract more than 500 industry experts from domestic and foreign pharmaceutical companies, biotechnology companies, governments, associations, law firms, intellectual property agents and other companies to attend.Agenda Framework:Section 1:Interpretation of Policy: Development of Pharmaceutical IP under the New Legislative Landscape Section 2:Pharmaceutical R&D Innovation and IP Protection -- Global VisionSection 3:Case Sharing of Pharmaceutical Patent Invalidity, Infringement, LitigationSection 4:Opportunities and challenges for generics companies under the new situation HOTSPOT:ü Medical Policy Interpretation under the Background of Patent Law Amendmentü The innovation of Judicial Mechanism Promotes the Development of Pharmaceutical Intellectual Propertyü Intellectual Property Management Experience in Multinational Pharmaceutical Companies, Patent Layout Strategy, Litigation Strategyü he Data Protection Regulations of Drug Test—New Eraü Trade Secrets and Patent Layout in the Medical Fieldü Establishing The Internal Intellectual Property System under The New Legislative Landscapeü Opportunities and Challenges of Pharmaceutical Enterprises under Patent Term Compensation System--- Global Vision and Its Implications for Chinaü Latest Changes in European Patent Application and Review Proceduresü Analysis of Hot Cases of Recent Patent Invalidationü The Procedure of American Pharmaceutical Patent litigation and its Enlightenment to Chinese Pharmaceutical Enterprises ü Application techniques and protection strategies for European and American biomedical patentsü Changes in standards for creative review of patentsü European, American and Japanese Medical Patent Examination Cases and its implications for DomesticPharmaceutical Companiesü Recent Hot Patent Infringement Cases Analysisü The Strategy of Indian Generic Drug Companies in R&D and Pre-PAü How to avoid the Patent Trap in Generic Drug Developmentü The Strategy of Generic Drug Companies to Enter the European and American Marketsü Patentability in Europe, the United States and Chinaü Patent litigation in Europeü Doubts around the Unified Patent Court (UPC) agreement and Brexitü Second medical use patentsComposition of participants: Summit highlights:10+ Hot topic20+ Authoritative speech5 0+ Industry media4 0+ BIC110+pharma company 500+專業參會嘉賓 Professional participantsOfficial registration and consultation channels:Contact:AnnPhone: 021-65650305Email:Marketing@zenseegroup.comhttp://en.zenseegroup.com/p/510934/